Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Pryma

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2022
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for NeuroblastomaVandana Batra, Minu Samanta, Mehran Makvandi, et al.
Pancreas|September 14, 2017
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective AnalysisBryson W Katona, Giorgio A Roccaro, Michael C Soulen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 19, 2026
Prospective exploratory pilot study of 18 F-FMISO PET/CT for assessing tumor hypoxia in soft tissue sarcomasRonnie Sebro, Ashley M Fuller, T S Karin Eisenger-Matheson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2020
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide TherapyThomas A Hope, Lisa Bodei, Jennifer A Chan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2015
A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688Lale Kostakoglu, Fenghai Duan, Michael O Idowu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2011
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PETJoseph A O'Donoghue, Peter M Smith-Jones, John L Humm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET Images of Ovarian CancerAnthony J Young, Austin R Pantel, Varsha Viswanath, et al.
JAMA Oncology|August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 TrialRamesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 24, 2013
Impact of PET staging in limited-stage small-cell lung cancerEric P Xanthopoulos, Michael N Corradetti, Nandita Mitra, et al.
Nuclear Medicine and Biology|May 4, 2020
Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [<sup>68</sup>Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studiesRobert K Doot, Anthony J Young, Margaret E Daube-Witherspoon, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2022
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for NeuroblastomaVandana Batra, Minu Samanta, Mehran Makvandi, et al.
Pancreas|September 14, 2017
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective AnalysisBryson W Katona, Giorgio A Roccaro, Michael C Soulen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 19, 2026
Prospective exploratory pilot study of 18 F-FMISO PET/CT for assessing tumor hypoxia in soft tissue sarcomasRonnie Sebro, Ashley M Fuller, T S Karin Eisenger-Matheson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2020
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide TherapyThomas A Hope, Lisa Bodei, Jennifer A Chan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2015
A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688Lale Kostakoglu, Fenghai Duan, Michael O Idowu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2011
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PETJoseph A O'Donoghue, Peter M Smith-Jones, John L Humm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET Images of Ovarian CancerAnthony J Young, Austin R Pantel, Varsha Viswanath, et al.
JAMA Oncology|August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 TrialRamesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 24, 2013
Impact of PET staging in limited-stage small-cell lung cancerEric P Xanthopoulos, Michael N Corradetti, Nandita Mitra, et al.
Nuclear Medicine and Biology|May 4, 2020
Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [<sup>68</sup>Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studiesRobert K Doot, Anthony J Young, Margaret E Daube-Witherspoon, et al.
Pageof 13